Journal of Assisted Reproduction and Genetics

, Volume 24, Issue 12, pp 621–627 | Cite as

Mild ovarian stimulation

  • Jerome H. CheckEmail author
Symposium of the Aging Ovary



To evaluate the efficacy of using only mild ovarian stimulation protocols for in vitro fertilization. Both groups with decreased and normal ovarian reserve were evaluated.


Three different mild stimulation protocols were evaluated: natural with no exogenous follicle stimulation hormone (FSH) drugs at all, natural with a boost of low dose FSH to complete follicular maturation, and minimal stimulation with low dose (75-150IU) FSH from day 3–5 of the menstrual cycle. Ethinyl estradiol was sometimes used to lower high day 3 serum FSH.


Good pregnancy and implantation rates were found even in those women with elevated serum FSH that could only generate one follicle.


Mild ovarian stimulation seems preferable to high dose FSH regimens in women with elevated day 3 serum FSH based on previous poor reported pregnancy rates with the latter protocols. Comparable pregnancy rates to high dose regimen were seen in women with normal egg reserve at much lower risk and cost.


Pregnancy Rate Follicle Stimulate Hormone Ethinyl Estradiol Control Ovarian Hyperstimulation Single Embryo Transfer 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Check JH, Chase J. Ovulation induction in hypergonadotropic amenorrhea with estrogen and human menopausal gonadotropin therapy. Fertil Steril 1984;42:919–22.PubMedGoogle Scholar
  2. 2.
    Check JH, Wu CH, Check M. The effect of leuprolide acetate in aiding induction of ovulation in hypergonadotropic hypogonadism: A case report. Fertil Steril 1988;49(3):542–3.PubMedGoogle Scholar
  3. 3.
    Check JH, Wu CH, Dietterich C, Lauer C, Liss J. The treatment of cervical factor with ethinyl estradiol and human menopausal gonadotropins. Int J Fertil 1986;31:148–52.PubMedGoogle Scholar
  4. 4.
    Check JH, Chase JS, Wu CH, Adelson HG. Ovulation induction and pregnancy with an estrogen-gonadotropin stimulation technique in a menopausal woman with marked hypoplastic ovaries. Fertil Steril 1989;160:405–6.Google Scholar
  5. 5.
    Check JH, Nowroozi K, Chase JS, Nazari A, Shapse D, Vaze M. Ovulation induction and pregnancies in 100 consecutive women with hypergonadotropic amenorrhea. Fertil Steril 1990;53(5):811–6.PubMedGoogle Scholar
  6. 6.
    Check ML, Check JH, Choe JK, Berger GS. Successful pregnancy in a 42-year-old woman with imminent ovarian failure following ovulation induction with ethinyl estradiol without gonadotropins and in vitro fertilization. Clin Exp Obstet Gynecol 2002;29:11–4.PubMedGoogle Scholar
  7. 7.
    Check JH. Multiple follicles in an unstimulated cycle despite elevated gonadotropins in a perimenopausal female. Gynecol Obstet Investig 1992;33:190–2.Google Scholar
  8. 8.
    Check JH. Progesterone therapy versus follicle maturing drugs—possible opposite effects on embryo implantation. Clin Exp Obstet Gynecol 2002;29:5–10.PubMedGoogle Scholar
  9. 9.
    Check JH, Nowroozi K, Wu CH, Adelson HG, Lauer C. Ovulation-inducing drugs versus progesterone therapy for infertility in patients with luteal phase defects. Int J Fertil 1988;33(4):252–6.PubMedGoogle Scholar
  10. 10.
    Check JH, Adelson H, Lurie D, Jamiston T. Effect of the short follicular phase on subsequent conception. Gynecol Obstet Investig 1992;34:180–3.CrossRefGoogle Scholar
  11. 11.
    Check JH, Liss JR, Shucoski K, Check ML. Effect of short follicular phase with follicular maturity on conception outcome. Clin Exp Obstet Gynecol 2003;30:195–6.PubMedGoogle Scholar
  12. 12.
    Check JH, Chase JS, Nowroozi K, Dietterich CJ. Premature luteinization: treatment and incidence in natural cycles. Hum Reprod 1991;6:190–3.PubMedGoogle Scholar
  13. 13.
    Check JH, Check ML, Katsoff D. Three pregnancies despite elevated serum FSH and advanced age. Hum Reprod 2000;15:1709–12.PubMedCrossRefGoogle Scholar
  14. 14.
    Katsoff B, Check MD. Successful pregnancy in a 45-year-old woman with elevated day 3 serum follicle stimulating hormone and a short follicular phase. Clin Exp Obstet Gynecol 2005;32:97–8.PubMedCrossRefGoogle Scholar
  15. 15.
    Check JH. Successful pregnancy despite advanced age and elevated serum follicle stimulating hormone levels—a case report. Clin Exp Obstet Gynecol 2000;27:171–2.PubMedGoogle Scholar
  16. 16.
    Check JH, Peymer M, Lurie D. Effect of age on pregnancy outcome without assisted reproductive technology in women with elevated early follicular phase serum follicle-stimulating hormone levels. Gynecol Obstet Investig 1998;45:217–20.CrossRefGoogle Scholar
  17. 17.
    Check JH, Nazari P, Check ML, Choe JK, Liss JR. Prognosis following in vitro fertilization–embryo transfer (IVF–ET) in patients with elevated day 2 or 3 serum follicle stimulating hormone (FSH) is better in younger vs. older patients. Clin Exp Obstet Gynecol 2002;29:42–4.PubMedGoogle Scholar
  18. 18.
    Check JH, Summers-Chase D, Yuan W, Horwath D, Wilson C. Effect of embryo quality on pregnancy outcome following single embryo transfer in women with a diminished egg reserve. Fertil Steril 2007;87:749–56.PubMedCrossRefGoogle Scholar
  19. 19.
    Check ML, Check JH, Wilson C, Choe JK, Krotec J. Outcome of in vitro fertilization–embryo transfer according to age in poor responders with elevated baseline serum follicle stimulation hormone using minimal or no gonadotropin stimulation. Clin Exp Obstet Gynecol 2004;31:183–4.PubMedGoogle Scholar
  20. 20.
    Muasher SJ, Oehninger S, Simonetti S, Matta J, Ellis LM, Liu H-C, et al. The value of basal and/or stimulated serum gonadotropin levels in prediction of stimulation response and in vitro fertilization outcome. Fertil Steril 1988;50:298–307.PubMedGoogle Scholar
  21. 21.
    Scott RT, Toner JP, Muasher SJ, Oehninger S, Robinson S, Rosenwaks Z. Follicle-stimulating hormone levels on cycle day 3 are productive of in vitro fertilization outcome. Fertil Steril 1989;51:651.PubMedGoogle Scholar
  22. 22.
    Roberts JE, Spandorfer S, Fasoulitotis SJ, Kashyap S, Rosenwaks Z. Taking a basal follicle-stimulating hormone history is essential before initiating in vitro fertilization. Fertil Steril 2005;83:37–41.PubMedCrossRefGoogle Scholar
  23. 23.
    Check JH, Fox F, Choe JK, Krotec JW, Nazari A. Sharing of oocytes from infertile versus paid donors results in similar pregnancy and implantation rates. Fertil Steril 2004;81:703–4.PubMedCrossRefGoogle Scholar
  24. 24.
    Check JH, Nowroozi K, Chase JS, Nazari A, Braithwaite C. Comparison of pregnancy rates following in vitro fertilization–embryo transfer between the donors and recipients in a donor oocyte program. J Assist Reprod Genet 1992;9(3):248–50.PubMedCrossRefGoogle Scholar
  25. 25.
    Check JH, O’Shaughnessy A, Lurie D, Fisher C, Adelson HG. Evaluation of the mechanism for higher pregnancy rates in donor oocyte recipients by comparison of fresh with frozen embryo transfer pregnancy rates in a shared oocyte programme. Hum Reprod 1995;10:3022–7.PubMedGoogle Scholar
  26. 26.
    Strandell A, Waldenstrom U, Nilsson L, Hamberger L. Hydrosalpinx reduces in vitro fertilization/embryo transfer pregnancy rates. Hum Reprod 1994;9:861.PubMedGoogle Scholar
  27. 27.
    Blazar AS, Hogan JW, Seifer DB, Frishman GN, Wheeler CA, Haning RV. The impact of hydrosalpinx on successful pregnancy in tubal factor infertility treated by in vitro fertilization. Fertil Steril 1997;67:517.PubMedCrossRefGoogle Scholar
  28. 28.
    Vandromme J, Chasse E, Lejeune B, Van Rysselberge M, Selvigne A, Leroy F. Hydrosalpinges in in vitro fertilization: an unfavorable prognostic feature. Hum Reprod 1995;10:576.PubMedGoogle Scholar
  29. 29.
    Shelton KE, Butler L, Toner JP. Salpingectomy improves the pregnancy rate in in vitro fertilization patients with hydrosalpinx. Hum Reprod 1996;11:523.PubMedGoogle Scholar
  30. 30.
    Puttemans PJ, Brosens IA. Salpingectomy improves in vitro fertilization outcome in patients with a hydrosalpinx: Blind victimization of the fallopian tube? Hum Reprod 1996;11:2079.PubMedGoogle Scholar
  31. 31.
    Check JH, Choe JK, Katsoff D, Summers-Chase D, Wilson C. Controlled ovarian hyperstimulation adversely affects implantation following in vitro fertilization–embryo transfer. J Assist Reprod Genet 1999;16:416–20.PubMedCrossRefGoogle Scholar
  32. 32.
    Check JH, Choe JK, Nazari A, Fox F, Swenson K. Fresh embryo transfer is more effective than frozen ET for donor oocyte recipients but not for donors. Hum Reprod, 2001;16:1403–8.CrossRefGoogle Scholar
  33. 33.
    Check JH, Check ML. Evidence that failure to conceive despite apparent correction of ovulatory defects by follicle-maturing drugs may be related to premature trophoblast invasion. Med Hypotheses 2002 Oct;59(4):385–8.CrossRefGoogle Scholar
  34. 34.
    Check JH, Nazari P, Check ML, Szekeres-Bartho J, Yuan W. Evidence that the adverse effect of controlled ovarian hyperstimulation on successful pregnancy outcome following embryo transfer may be related to premature trophoblast invasion. Clin Exp Obstet Gynecol 2002;29:83–6.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  1. 1.Division of Reproductive Endocrinology & Infertility, Department of Obstetrics and GynecologyCooper Hospital/University Medical Center, Robert Wood Johnson Medical School at Camden, The University of Medicine and Dentistry of New JerseyCamdenUSA
  2. 2.PhiladelphiaUSA

Personalised recommendations